SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

An increase of about 720.63% to Rs. 188.91 millions in the total revenue was observed for the quarter ended December 2023. The total revenue was pegged at Rs. 23.02 millions during the similar quarter previous year.The Net Profit of the company reported a remarkable increase of 36130.77% to Rs. 94.20  millions  from Rs. 0.26 millions in previous same quarter.OP of the company witnessed a marginal growth to 101.06 millions from 5.55 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 188.91 23.02 720.63 636.89 125.89 405.91 588.34 204.86 187.19
Other Income 5.62 2.69 108.92 14.39 3.06 370.26 11.97 0.81 1377.78
PBIDT 101.06 5.55 1720.90 164.08 20.16 713.89 65.60 29.67 121.10
Interest 0.66 0.50 32.00 2.16 2.08 3.85 2.81 2.87 -2.09
PBDT 100.40 5.05 1888.12 161.92 18.08 795.58 62.79 26.80 134.29
Depreciation 5.12 4.59 11.55 15.33 13.32 15.09 18.38 16.62 10.59
PBT 95.28 0.46 20613.04 146.59 4.76 2979.62 44.41 10.18 336.25
TAX 1.08 0.20 440.00 1.08 0.48 125.00 0.35 2.67 -86.89
Deferred Tax 0.04 0.20 -80.00 0.02 0.40 -95.00 0.27 0.56 -51.79
PAT 94.20 0.26 36130.77 145.51 4.28 3299.77 44.06 7.51 486.68
Equity 109.47 15.66 599.04 109.47 15.66 599.04 39.14 15.66 149.94
PBIDTM(%) 53.50 24.11 121.89 25.76 16.01 60.88 11.15 14.48 -23.01

Shukra Pharma Share Price

36.06 0.71 (2.01%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×